Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

a-s medication solutions - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precaution (5.1) for statement regarding fatal hepatic dysfunction. because of the risk to the fetus of decreased iq, neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless the drug is essential to the man

Israel - Tiếng Anh - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 500 mg - valproic acid - valproic acid - generalized or partial epilepsy, secondary generalized epilepsy, mixed forms of epilepsy.

Israel - Tiếng Anh - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - syrup - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

Israel - Tiếng Anh - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 200 mg - valproic acid - valproic acid - anti-epileptic.

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - valproic acid 145 mg; sodium valproate 333 mg - prolonged-release tablet - 500 mg - valproate sodium 333 mg; valproic acid 145 mg - valproic acid

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

clinical solutions wholesale - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

remedyrepack inc. - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

contract pharmacy services-pa - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings for statement regarding fatal hepatic dysfunction. valproic acid should not be administered to patients with hepatic disease or significant hepatic dysfunction. valproic acid is contraindicated in patients with known hypersensitivity to the drug. valproic acid is contraindicated in patients with known urea cycle disorders (see warnings

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - valproic acid 87 mg; sodium valproate 200 mg - prolonged-release tablet - 300 mg - valproic acid 87 mg; valproate sodium 200 mg - valproic acid

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - sodium valproate 333 mg; valproic acid 145 mg - prolonged-release tablet - 500 mg - valproic acid 145 mg; valproate sodium 333 mg - valproic acid